Sunday, December 22, 2024
- Advertisement -spot_img

TAG

ANR

Anatara Lifesciences embarks on Stage 2 of GaRP trial for treatment of irritable bowel syndrome

Anatara Lifesciences (ASX: ANR) has initiated Stage 2 of a Phase II gastrointestinal re-programming (GaRP) trial to treat patients with irritable bowel syndrome (IBS). The...

Latest news

- Advertisement -spot_img